Crossmark

Anti-Carbamylated Protein Antibodies, Tumour Necrosis Factor Alpha and Insulin Resistance in Egyptian Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.08.002

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

El Hawary, Mohamed Sherif

Hassan, Sarah A.

ELatty, Sahar Abd

Khalil, Noha M.
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Anti-Carbamylated Protein Antibodies, Tumour Necrosis Factor Alpha and Insulin Resistance in Egyptian Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.08.002

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below